Vanguard U.S. Multifactor Fund BMY Holdings History
Vanguard U.S. Multifactor Fund's Bristol-Myers Squibb Co Holding Summary
As of 2025-02-28, VANGUARD WELLINGTON FUND held 25,452.00 shares of Bristol-Myers Squibb Co(BMY), totaling $1.52 Mil. This investment constitutes 0.83% of their stock portfolio, and VANGUARD WELLINGTON FUND now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2021Q4. And since then Vanguard U.S. Multifactor Fund has made 4 purchases of BMY, at an average price of $58.37, for a total of 37,314.00 shares. In addition, there have been 6 sales at an average price of $59.52 for 11,862.00 shares. Based on historical transaction data and BMY's current price of $48.06, Vanguard U.S. Multifactor Fund's estimated gain on his BMY holdings is $-248,759.02, reflecting a -11.42% gain to date.
Vanguard U.S. Multifactor Fund BMY ($48.06) Holding Chart
Vanguard U.S. Multifactor Fund BMY ($48.06) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
